Artículos por temáticas

Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease.

Kong G, Cao KL, Judd LM, Li S, Renoir T, Hannan AJ.

Neurobiol Dis. 2020 Feb;135:104268. doi: 10.1016/j.nbd.2018.09.001. Epub 2018 Sep 5.

Progressive microstructural changes of the occipital cortex in Huntington's disease.

Odish OFF, Reijntjes RHAM, van den Bogaard SJA, Roos RAC, Leemans A.

Brain Imaging Behav. 2018 Feb 28. doi: 10.1007/s11682-018-9849-5. [Epub ahead of print]

DNA Methylation Profiles in Whole Blood of Huntington's Disease Patients.

Zadel M, Maver A, Kovanda A, Peterlin B.

Front Neurol. 2018 Aug 14;9:655. doi: 10.3389/fneur.2018.00655. eCollection 2018.

Pharmacogenetic modulation of STEP improves motor and cognitive function in a mouse model of Huntington's disease.

García-Forn M, Martínez-Torres S, García-Díaz Barriga G, Alberch J, Milà M, Azkona G, Pérez-Navarro E.

Neurobiol Dis. 2018 Aug 31;120:88-97. doi: 10.1016/j.nbd.2018.08.024. [Epub ahead of print]

Retinal single-layer analysis with optical coherence tomography shows inner retinal layer thinning in Huntington's disease as a potential biomarker.

Gulmez Sevim D, Unlu M, Gultekin M, Karaca C.

Int Ophthalmol. 2018 Feb 12. doi: 10.1007/s10792-018-0857-7. [Epub ahead of print]

Adeno-Associated Viral Vector Serotype DJ-Mediated Overexpression of N171-82Q-Mutant Huntingtin in the Striatum of Juvenile Mice Is a New Model for Huntington's Disease.

Jang M, Lee SE, Cho IH.

Front Cell Neurosci. 2018 Jun 12;12:157. doi: 10.3389/fncel.2018.00157. eCollection 2018.

Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease.

Niemelä V, Burman J, Blennow K, Zetterberg H, Larsson A, Sundblom J.

PLoS One. 2018 Feb 23;13(2):e0193492. doi: 10.1371/journal.pone.0193492. eCollection 2018.

Cilostazol disrupts TLR-4, Akt/GSK-3β/CREB, and IL-6/JAK-2/STAT-3/SOCS-3 crosstalk in a rat model of Huntington's disease.

El-Abhar H, Abd El Fattah MA, Wadie W, El-Tanbouly DM.

PLoS One. 2018 Sep 27;13(9):e0203837. doi: 10.1371/journal.pone.0203837. eCollection 2018.

Type 2 Diabetes Presenting With Persistent Chorea.

Chalia M, Subramanian T.

JAMA Neurol. 2018 Dec 21. doi: 10.1001/jamaneurol.2018.4089. [Epub ahead of print] No abstract available.

Comparative transcriptomics of choroid plexus in Alzheimer's disease, frontotemporal dementia and Huntington's disease: implications for CSF homeostasis.

Stopa EG, Tanis KQ, Miller MC, Nikonova EV, Podtelezhnikov AA, Finney EM, Stone DJ, Camargo LM, Parker L, Verma A, Baird A, Donahue JE, Torabi T, Eliceiri BP, Silverberg GD, Johanson CE.

Fluids Barriers CNS. 2018 May 31;15(1):18. doi: 10.1186/s12987-018-0102-9.

Brain pericyte activation occurs early in Huntington's disease.

Padel T, Roth M, Gaceb A, Li JY, Björkqvist M, Paul G.

Exp Neurol. 2018 Jul;305:139-150. doi: 10.1016/j.expneurol.2018.03.015. Epub 2018 Apr 7.

Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6/2 mouse model of Huntington's disease.

Giampà C, Alvino A, Magatti M, Silini AR, Cardinale A, Paldino E, Fusco FR, Parolini O.

J Cell Mol Med. 2018 Dec 25. doi: 10.1111/jcmm.14113. [Epub ahead of print]

Design of Bivalent Nucleic Acid Ligands for Recognition of RNA-Repeated Expansion Associated with Huntington's Disease.

Thadke SA, Perera JDR, Hridya VM, Bhatt K, Shaikh AY, Hsieh WC, Chen M, Gayathri C, Gil RR, Rule GS, Mukherjee A, Thornton CA, Ly DH.

Biochemistry. 2018 Mar 27. doi: 10.1021/acs.biochem.8b00062. [Epub ahead of print]

Spontaneous Intracranial Hypotension as a Cause of Exacerbation in Huntington's Disease.

Figueroa EL, Jog MS, Pelz DM, Lownie SP.

Can J Neurol Sci. 2018 May;45(3):357-359. doi: 10.1017/cjn.2017.296. No abstract available.

Huntington's disease: the coming of age.

Pandey M, Rajamma U.

J Genet. 2018 Jul;97(3):649-664.